Linguistic and cultural adaptation and validation of the questionnaire on vulvovaginal symptoms among the patients with vulvovaginal atrophy

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: To carry out linguistic and cultural adaptation and validation of the English-language version of the Vulvovaginal Symptoms Questionnaire (VSQ) proposed by the North American Menopause Society (NAMS) as an effective tool for assessing the severity of symptoms of vulvovaginal atrophy (VVA), as well as the effectiveness of its treatment.

Materials and methods: Following the protocols of such studies, the forward-backward translation of the VSQ questionnaire was done. Subsequently, an intermediate Russian-language version of the questionnaire was completed by 20 patients. After finding and correcting the discrepancies, the final Russian-language version of the VSQ questionnaire was approved. The study group included 120 postmenopausal patients with symptoms of VVA who completed the questionnaire twice (test-retest) with an interval of 10–14 days.

Results: The statistical analysis of the data (Cronbach’s α=0.983) showed a high degree of reliability of the test results. This conclusion is also supported by very high indicators of retest reliability of the questionnaire (ICC>0.9). The results of the intra-class correlation coefficient and retest reliability of the Russian-language version of the VSQ questionnaire prove that it is a reliable and valid tool for assessing the severity of the VVA symptoms.

Conclusion: The research findings show that the Russian-language version of the VSQ questionnaire is an effective, reliable and valid method for the subjective assessment of the severity of the VVA symptoms. It is recommended to use this questionnaire in research and in the daily practice of gynecologists including the assessment of therapy effectiveness.

Full Text

Restricted Access

About the authors

Inna A. Apolikhina

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Author for correspondence.
Email: i_apolikhina@oparina4.ru

Dr. Med. Sci., Professor, Head of the Department of Aesthetic Gynecology and Rehabilitation

Russian Federation, Moscow; Moscow

Svetlana N. Kazakova

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: s-juice@mail.ru

post-graduate student of the Department of Obstetrics, Gynecology, Perinatology and Reproductology

Russian Federation, Moscow

Ekaterina L. Yarotskaya

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: e_yarotskaya@oparina4.ru

Dr. Med. Sci., Head of the Department of International Cooperation

Russian Federation, Moscow

Elena A. Gorbunova

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: el_gorbunova@oparina4.ru

obstetrician-gynecologist at the Department of Aesthetic Gynecology and Rehabilitation

Russian Federation, Moscow

Anastasia E. Bychkova

Academician V.I. Kulakov National Medical Research Centre for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: a_bychkova@oparina4.ru

obstetrician-gynecologist at the Department of Aesthetic Gynecology and Rehabilitation

Russian Federation, Moscow

References

  1. Тихомирова Е.В., Балан В.Е., Фомина-Нилова О.С. Методы лечения генитоуринарного синдрома на современном этапе. Медицинский совет. 2020; 13: 91-6. [Tikhomirova E.V., Balan V.E., Fomina-Nilova O.S. Current treatment options for genitourinary syndrome. Medical Council. 2020;( 13): 91-6. (in Russian)]. https://dx.doi.org/ 10.21518/2079-701X-2020-13-91-96.
  2. Mehta A., Bachmann G. Vulvovaginal complaints. Clin. Obstet. Gynecol. 2008; 51(3): 549-55. https://dx.doi.org/10.1097/GRF.0b013e3181809a26.
  3. Аполихина И.А., Юренева С.В., Малышкина Д.А. Генитоуринарный менопаузальный синдром: современные подходы к диагностике и лечению. Акушерство и гинекология. 2020; 12(Приложение): 4-8. [Apolikhina I.A., Yureneva S.V., Malyshkina D.A. Genitourinary menopausal syndrome: modern approaches to diagnosis and treatment. Obstetrics and Gynecology. 2020; (12, Suppl.): 4-8. (in Russian)].
  4. Аполихина И.А., Горбунова Е.А. Клинико-морфологические аспекты вульвовагинальной атрофии. Медицинский cовет. 2014; 9: 110-7. [Apolikhina I.A., Gorbunova E.A. Clinical and morphological aspects of vulvovaginal atrophy. Medical Council. 2014; (9): 110-7. (in Russian)]. https://dx.doi.org/10.21518/2079-701X-2014-9-110-117.
  5. Palma F., Volpe A., Villa P., Cagnacci A.; Writing group of AGATA study. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study. Maturitas. 2016; 83: 40-4. https://dx.doi.org/10.1016/j.maturitas.2015.09.001.
  6. Johnston S., Bouchard C., Fortier M., Wolfman W. Guideline No. 422b: Menopause and genitourinary health. J. Obstet. Gynaecol. Can. 2021; 43(11): 1301-17.e1. https://dx.doi.org/10.1016/j.jogc.2021.09.001.
  7. Palacios S., Nappi R.E., Bruyniks N., Particco M., Panay N.; EVES Study Investigators. The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause. Climacteric. 2018; 21(3): 286-91. https://dx.doi.org/10.1080/ 13697137.2018.1446930.
  8. Erekson E.A., Yip S.O., Wedderburn T.S., Martin D.K., Li F.Y., Choi J.N. et al. The Vulvovaginal Symptoms Questionnaire: a questionnaire for measuring vulvovaginal symptoms in postmenopausal women. Menopause. 2013; 20(9): 973-9. https://dx.doi.org/10.1097/GME.0b013e318282600b.
  9. Gardner A.N., Aschkenazi S.O. The short-term efficacy and safety of fractional CO2 laser therapy for vulvovaginal symptoms in menopause, breast cancer, and lichen sclerosus. Menopause. 2021; 28(5): 511-6. https://dx.doi.org/10.1097/GME.0000000000001727.
  10. Takacs P., Kozma B., Erdodi B., Jakab A., Larson K., Poka R. Zinc-containing vaginal moisturizer gel improves postmenopausal vulvovaginal symptoms: a pilot study. J. Menopausal Med. 2019; 25(1): 63-8. https://dx.doi.org/10.6118/jmm.2019.25.1.63.
  11. González-Isaza P., Lotti T., França K., Sanchez-Borrego R., Tórtola J.E., Lotti J. et al. Carbon dioxide with a new pulse profile and shape: a perfect tool to perform labiaplasty for functional and cosmetic purpose. Open Access Maced. J. Med. Sci. 2018; 6(1): 25-7. https://dx.doi.org/10.3889/oamjms.2018.043.
  12. Саидова А.С., Сенча А.Н., Аполихина И.А. Карбокситерапия генитоуринарного менопаузального синдрома. Акушерство и гинекология. 2020; 5: 113-21. [Saidova A.S., Sencha A.N., Apolikhina I.A. Carboxytherapy of genitourinary syndrome of menopause. Obstetrics and Gynecology. 2020; (5): 113-21 (in Russian)]. https://dx.doi.org/10.18565/aig.2020.5.113-21.
  13. Доброхотова Ю.Э., Ильина И.Ю., Венедиктова М.Г., Морозова К.В., Суворова В.А., Утина М.С., Залесская С.А. Применение эрбиевого лазера в лечении генитоуринарного синдрома у пациенток после радикального лечения рака тела матки. Акушерство и гинекология. 2019; 6: 48-54. [Dobrokhotova Yu.E., Il’ina I.Yu., Venediktova M.G., Morozova K.V., Suvorova V.A., Utina M.S., Zalesskaya S.A. Erbium laser in the management of the genitourinary syndrome in patients after radical therapy for uterine cancer. Obstetrics and Gynecology. 2019; (6): 48-54. (in Russian)]. https://dx.doi.org/10.18565/aig.2019.6.48-54.
  14. Кузнецов И.А., Майков С.В., Салихов М.Р., Шулепов Д.А., Авдеев А.И. Языковая, культурная адаптация и валидация опросника Kujala среди пациентов с болями в переднем отделе коленного сустава. Научно-практическая ревматология. 2017; 55(4): 388-92. [Kuznetsov I.A., Maikov S.V., Salikhov M.R., Shulepov D.A., Avdeev A.I. Linguistic and cultural adaptation and validation of the Kujala questionnaire among patients with pain in the anterior part of knee joint. Rheumatology Science and Practice. 2017; 55(4): 388-92. (in Russian)]. https://dx.doi.org/10.14412/ 1995-4484-2017-388-392.
  15. Guillemin F., Bombardier C., Beaton D. Cross-cultural adaptation of healthrelated quality of life measures: literature review and proposed guidelines. J. Clin. Epidemiol. 1993; 46(12): 1417-32. https://dx.doi.org/10.1016/ 0895-4356(93)90142-N.
  16. Runkin G., Stokes M. Reliability of assessment tools in rehabilitation: an illustration of appropriate statistical analyses. Clin. Rehabil. 1998; 12(3): 187-99. https://dx.doi.org/10.1191/026921598672178340.
  17. Cronbach L.J. Coefficient alpha and the internal structure of tests. Psychometrika. 1951; 16(3): 297-34.
  18. Santos-de-Araújo A.D., Dibai-Filho A.V., Pontes-Silva A., Rêgo A.S., Santos D.L.D., Mendes Júnior A.A. et al. Translation, cross-cultural adaptation, and validation of health and self-management in diabetes questionnaire (HASMID-10) into Brazilian Portuguese. Sao Paulo Med. J. 2023; 142(1): e2022681. https://dx.doi.org/10.1590/1516-3180.2022.0681.R1.10042023.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies